Episodio – Mutación KRAS y resistencia a terapias anti-EGFR | USMLE Step 1 episode artwork

EPISODE · Nov 28, 2025 · 6 MIN

Episodio – Mutación KRAS y resistencia a terapias anti-EGFR | USMLE Step 1

from USMLE DREAMERS · host USMLE DREAMERS

Paciente con cáncer colorrectal metastásico y anemia microcítica. Revisamos el eje EGFR–KRAS, por qué ciertos tumores responden a anticuerpos monoclonales como cetuximab/panitumumab, y cómo una mutación activadora en KRAS genera resistencia terapéutica. Alta integración entre oncología molecular, señalización celular y terapias dirigidas.#USMLE #Step1 #Oncologia #KRAS #EGFR #Cetuximab #Panitumumab #ColonCancer #USMLEDreamers #MolecularTargets #TargetedTherapy

Episode metadata supplied by the publisher feed · Published Nov 28, 2025

Embed this episode

NOW PLAYING

Episodio – Mutación KRAS y resistencia a terapias anti-EGFR | USMLE Step 1

0:00 6:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of USMLE DREAMERS?

This episode is 6 minutes long.

When was this USMLE DREAMERS episode published?

This episode was published on November 28, 2025.

Can I download this USMLE DREAMERS episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!